Clinical Trial to Evaluate the Efficacy and Safety in Nasolabial Fold After Rhytidectomy Using Non-absorbable Mesh
A Multi Center, Non-comparative Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety After Rhytidectomy Using Non-absorbable Mesh(RPM)
2 other identifiers
interventional
28
1 country
1
Brief Summary
The aim of this study is to evaluate the efficacy and safety of the investigational device, RPM,non-absorbable polypropylene mesh made by D Med, in correction of Nasolabial fold. Study hypothesis
- level of significance: alpha=0.05( two-side)
- power of test: (power= 1-beta),power=0.08
- H0: P equals P0
- H1: P unequals P0
- The difference between the changes in the WSRS(Wrinkle Severity Rating Scale) of the pre and post rhytidectomy from baseline at 7week after administration is 0.237( P-P0= 0.237)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 22, 2013
CompletedFirst Posted
Study publicly available on registry
January 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedJanuary 7, 2014
January 1, 2014
11 months
January 22, 2013
January 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change in the WSRS(Wrinkle Severity Rating Scale) of the pre and post rhytidectomy from baseline at 7week after administration
The efficacy is assessed by the severity of the fold determined by the WSRS assessed by the investigator with photos WSRS(Wrinkle Severity Rating Scale)is be evaluated from 1 to 5 according to the severity of wrinkles (1= no visible fold, 5= extremely deep and long fold)
change in the WSRS from baseline at7 week
Secondary Outcomes (1)
The changes in the satisfaction of the pre and post rhytidectomy from baseline at 7week after administration
Changes Satisfaction from baseline at 7week
Study Arms (1)
Non-absorbable polypropylene mesh
EXPERIMENTAL2 step procedures * first step is insertion of Non-absorbable polypropylene mesh under the facial skin * second step is pulling of Non-absorbable polypropylene mesh after 3 weeks of 1 step
Interventions
2 step procedures * first step is insertion of Non-absorbable polypropylene mesh under the facial skin * second step is pulling of Non-absorbable polypropylene mesh after 3 weeks of 1 step
Eligibility Criteria
You may qualify if:
- Subjects who had soft tissue sagging around nasolabial fold
- Female aged between 30 and 65, having grade 3 or 4 of nasolabial fold as Wrinkle severity Rating Scale(WSRS)
- Subjects who voluntary decided to participate in the study and signed the informed consent
You may not qualify if:
- Subjects who have a skin disease on the face
- Subjects who have severe facial skin disease
- Subjects who are constantly taking anti-coagulants including aspirin
- Subjects who have too thin or thick skin
- Subjects who have a systemic disease such as uncontrolled high blood pressure, diabetes, heart disease
- Subjects who had an allergy to non-absorbable material.
- Subjects who are taking immune suppressants
- General weakness status
- Pregnant or lactating women
- Subjects who have an asthma, cancer, AIDS, Cystic fibrosis, Immobility cilia syndrome, leukopenia, Immunoglobulin deficiency, active infectious disease, serious liver or renal disease,
- Subjects who had a history of dermal augmentation surgery with permanent implants(e.g. silicone, Softform®)on the face
- Subjects who participated in other clinical trial within 30 days from screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- D.medcollaborator
Study Sites (1)
Korea University Anam Hospital
Seoul, Seongbukgu/Seoul, 136-705, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Chanyeong Heo, Master
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2013
First Posted
January 24, 2013
Study Start
January 1, 2013
Primary Completion
December 1, 2013
Study Completion
January 1, 2014
Last Updated
January 7, 2014
Record last verified: 2014-01